{"id":881,"date":"2011-09-25T12:55:37","date_gmt":"2011-09-25T16:55:37","guid":{"rendered":"http:\/\/blogs.cooperhealth.org\/sjmedicalreport\/?p=881"},"modified":"2016-12-15T17:58:40","modified_gmt":"2016-12-15T17:58:40","slug":"the-gynecologic-oncology-center-at-cooper-cancer-institute-on-the-forefront-of-today%e2%80%99s-most-advanced-treatments","status":"publish","type":"post","link":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/2011\/09\/25\/the-gynecologic-oncology-center-at-cooper-cancer-institute-on-the-forefront-of-today%e2%80%99s-most-advanced-treatments\/","title":{"rendered":"The Gynecologic Oncology Center at Cooper Cancer Institute on the Forefront of Today\u2019s Most Advanced Treatments"},"content":{"rendered":"

With five fellowship-trained subspecialists, the Gynecologic Oncology Center at Cooper Cancer Institute is the largest program of its kind in New Jersey<\/strong>. But what truly distinguishes the Center is the team\u2019s depth of experience and expertise in innovative diagnostic and treatment technologies, and its comprehensive clinical\u00a0and supportive care services.<\/p>\n

\u201cThere\u2019s no reason to send any South Jersey patient with ovarian, cervical or uterine cancer to any other hospital,\u201d says David P. Warshal, MD, Head of Cooper\u2019s Division of Gynecologic Oncology. \u201cWe provide virtually every aspect of gynecologic oncology care; and, with five offices located throughout South Jersey, and one in Langhorne, PA, access to advanced care is exceptionally convenient.\u201d<\/p>\n

ADVANCED DIAGNOSTIC AND TREATMENT TECHNOLOGIES<\/strong>
\nCooper gynecologic oncologists use sophisticated diagnostic and therapeutic technologies including intraperitoneal chemotherapy, CyberKnife\u00ae radiosurgery, robotic-assisted surgery with the da Vinci\u00ae\u00a0Surgical System and minimally invasive surgery.<\/p>\n

Intraperitoneal chemotherapy is a significant weapon in the Center\u2019s arsenal for treating ovarian cancer. This highly specialized treatment, in which chemotherapy is delivered directly into the abdominal cavity via catheter, has been shown to extend survival by up to 16 months in patients with advanced ovarian cancer who have achieved optimal results from surgery to debulk their tumors. Intraperitoneal chemotherapy is a rigorous treatment option that demands a high level of clinical expertise to manage toxicity issues.<\/p>\n

\u201cOver half of all our patients with advanced ovarian cancer are candidates for this treatment,\u201d says Dr. Warshal. \u201cAnd we are the only practice in South Jersey to offer it.\u201d<\/p>\n

\u201cCyberKnife is a non-invasive alternative to surgery for the treatment of isolated recurrences of cervical, ovarian and endometrial tumors,\u201d says Dr. Warshal. \u201cWe work closely with our colleagues in radiation\u00a0oncology to develop and implement a treatment plan for our patients using this innovative technology.\u201d<\/p>\n

With its pinpoint precision, CyberKnife is particularly effective in treating complex and difficult-to-reach tumors. Appropriate patients can be treated in as few as one to five outpatient visits compared to traditional\u00a0radiation therapy which is administered over weeks or months.<\/p>\n

A MULTIDISCIPLINARY APPROACH TO CARE<\/strong>
\nCooper\u2019s gynecologic oncologists participate in weekly, multidisciplinary gynecologic tumor conferences.\u00a0Specialists from various disciplines \u2013 radiation oncology, pathology, radiology and other cancer specialties \u2013 work together to provide their patients with the most advanced diagnostic and treatment technologies available, access to groundbreaking clinical trials and dynamic patient-physician relationships. A full complement of support services including nutrition counseling, genetic testing and counseling, palliative care, social work services, physical rehabilitation, complementary medicine therapies and behavioral health support provide complete care for our patients.<\/p>\n

One of the most important members of the care team is the Gynecologic Cancer Nurse Navigator Susan Maltman, RN, MSN, OCN. Susan serves as a patient advocate and educator and helps newly diagnosed patients navigate their care across the full continuum of cancer services.<\/p>\n

PRESERVING FERTILITY<\/strong>
\n\u201cWe never lose sight of the life-altering impact of cancer and its treatment on all aspects of a woman\u2019s life including future childbearing,\u201d Dr. Warshal emphasizes. \u201cWe can treat early-stage endometrial cancers\u00a0hormonally to preserve fertility. We are also one of a limited number of Centers preserving fertility in young women with early cervical cancers by performing a new, uterus-conserving surgical technique called\u00a0radical trachelectomy.\u201d<\/p>\n

CANCER GENETICS PROGRAM<\/strong>
\nApproximately 5 percent to 10 percent of all cancers are hereditary, meaning that they are related to a genetic\u00a0change that can be passed through the generations. Cooper Cancer Institute offers a Cancer Genetics Program to assess each patient\u2019s risk for hereditary breast, ovarian, uterine, colon and other cancers that may run in a family. Patients are empowered when provided with the information they need to make important decisions about genetic testing, as well as cancer treatment and prevention measures.<\/p>\n

CLINICAL RESEARCH<\/strong>
\nThe Gynecologic Oncology Center – the state\u2019s only full member of the Gynecologic Oncology Group (GOG) \u2013 is one of only 50 in the nation to meet the high standards for comprehensive care, advanced treatments and patient accrual to clinical trials that this status requires. GOG is a National Cancer Institute-supported research cooperative, giving patients with gynecologic malignancies access to novel therapies through an active clinical trials network. Approximately 45 GOG-initiated clinical trials are active at any one time \u2013 and available to Cooper patients.<\/p>\n

To refer a patient, or for a physician-to-physician consultation with a member of the Cooper Gynecologic Oncology group, please call 856.325.6644.<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

With five fellowship-trained subspecialists, the Gynecologic Oncology Center at Cooper Cancer Institute is the largest program of its kind in New Jersey. <\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-dzarnosky","4":"has-excerpt","5":"post-881","7":"format-standard","8":"category-featured"},"_links":{"self":[{"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/posts\/881","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/comments?post=881"}],"version-history":[{"count":11,"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/posts\/881\/revisions"}],"predecessor-version":[{"id":1644,"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/posts\/881\/revisions\/1644"}],"wp:attachment":[{"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/media?parent=881"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/categories?post=881"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/tags?post=881"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}